Content for healthcare professionals only

View all Platforms Cardiology

Topics Content Type Videos Articles Journals Broadcasts Education Podcasts News Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events Resource Hubs Deep Vein Thrombosis Empagliflozin in the Treatment of Chronic Heart Failure Pulmonary Embolism Pulsed Field Ablation

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Content Type

Events

Resource Hubs

David J Cohen

David J Cohen

Director of Clinical and Outcomes Research

Cardiovascular Research Foundation & St Francis Hospital, Roslyn, NY, US

Expertise

Intervention Coronary Interventions Vascular Disease and Surgery Structural Intervention Coronary Physiology Standards & Guidelines

Media

PARTNER 3: TAVR is Cost Effective Compared with SAVR for Low-Risk Patients

Video

Intervention

PARTNER 3: TAVR is Cost Effective Compared with SAVR for Low-Risk Patients

Watch time: 7m 8s

USC 2021 Discussion: How Guidelines are Constructed & Elaborated

Video

Standards & Guidelines

Intervention

USC 2021 Discussion: How Guidelines are Constructed & Elaborated

Michael J Mack, David J Cohen, Mirvat Alasnag, et al

Watch time: 19m 20s

TCT 2017: The PARTNER 2A & SAPIEN 3 Cost-Effectiveness Studies

Video

Intervention

TCT 2017: The PARTNER 2A & SAPIEN 3 Cost-Effectiveness Studies

Watch time: 5m 30s

Articles by David J Cohen, Director of Clinical and Outcomes Research

Bioprosthetic Valve Fracture During Valve-in-valve TAVR: Bench to Bedside

John T Saxon, Keith B Allen, David J Cohen, et al

Citation: Interventional Cardiology Review 2018;13(1):20–6.

DOI:

https://doi.org/10.15420/icr.2017:29:1